UK's Croda to buy Korean bio materials maker for $286 mn

Korean PE firm SkyLake is expected to funnel the proceeds into the copper foil business amid rapid growth in the global EV sector

(Captured from Croda's website)
(Captured from Croda's website)
Chae-Yeon Kim 1
2023-02-02 19:18:54 why29@hankyung.com
Mergers & Acquisitions

Croda International Plc., a British specialty chemicals company, is set to acquire South Korean bio materials producer Solus Biotech Co. for some 350 billion won ($285.9 million).

SkyLake Equity Partners, a South Korean private equity firm, plans to sign a deal on Friday to sell its 100% stake in Solus Biotech to Croda, according to industry and investment banking sector sources in Seoul on Thursday.

SkyLake had selected Solvay S.A. as a preferred bidder for Solus Biotech late last year but failed to sell the company to the Belgian chemicals maker as they could not reach an agreement on details. The PE firm then approached other companies including Croda, German specialty chemicals company Evonik Industries AG and US food processing giant ADM.

Croda reportedly decided to take over Solus Biotech as the company is a major manufacturer of ceramide, a high-priced skin and hair care product material, with a 10% share in the global market, according to the sources.

The South Korean company was known to have reported earnings before interest, taxes, depreciation and amortization (EBITDA) of some 11 billion won last year with sales of 47 billion won.

FOR COPPER FOIL BUSINESS

Croda, which is listed on the London Stock Exchange, reorganized its business portfolio to switch its focus from petrochemicals to cosmetics materials through acquisitions.

The Snaith-based company founded in 1925 currently sells more than 140 cosmetics materials in the global market under brands such as Croda, Crodarom, Sederma and Alban Muller.

SkyLake, led by ex-Information and Communication Minister and Samsung Electronics Co. Digital Media President Chin Dae-je, bought Solus Advanced Materials Co., a copper foil producer, for about 700 billion won from South Korea’s Doosan Group in 2020.

SkyLake last year split off the bio business of Solus Advanced Materials to establish Solus Biotech.

The PE firm has been seeking the sale of the company to focus on copper foil, a key material for secondary batteries, given rapid growth in the global electric vehicle industry. It is expected to use the proceeds to invest in Solus Advanced Materials’ production facilities.

Write to Chae-Yeon Kim at why29@hankyung.com

Jongwoo Cheon edited this article.

Solvay named preferred bidder to buy Solus Biotech

Solvay named preferred bidder to buy Solus Biotech

(Courtesy of Getty Images) Belgian chemicals maker Solvay S.A. has been selected as the preferred bidder to acquire South Korean biomaterials maker Solus Biotech, according to investment banking sources on Dec. 28.If clinched, the deal is expected to be valued at about 350 billion won ($276.7 m

BASF, ADM join race to buy Korean ceramide maker Solus Biotech

BASF, ADM join race to buy Korean ceramide maker Solus Biotech

A researcher at Solus Biotech (Courtesy of Solus Biotech) BASF SE, the world’s largest chemical producer, US food processing giant ADM Co. and two other global companies have joined the race to acquire South Korean biomaterial maker Solus Biotech, according to investment banking sources o

Doosan Group inks sale of copper foil maker to PEF SkyLake for $588 mn

Doosan Group inks sale of copper foil maker to PEF SkyLake for $588 mn

Doosan Group has agreed to sell Doosan Solus Co. Ltd., a copper foil and OLED materials maker, to South Korean private equity firm SkyLake Investment Co., according to the companies' regulatory filings on September 4.The South Korean conglomerate will unload a 53% stake in Solus, held collectively b

(* comment hide *}